Piramal Enterprises Ltd. share price target

We attended Piramal Finance’s (PIEL) Piramal.AI day, where the company showcased its extensive use of AI across all business functions and demonstrated how it is driving improvements in efficiency and productivity.

We interacted with the senior management team of Piramal Enterprises (PIEL), represented by Mr. Jairam Sridharan, CEO of Retail Lending and MD of Piramal Finance, to gain insights into the company's future growth plans and other strategic developments.

Piramal Enterprises (PIEL) reported a 4QFY25 net profit of ~INR1b (PQ: ~INR386m). This included an exceptional gain of ~INR3.7b from recoveries in the AIF portfolio. For FY25, the total gain from the AIF portfolio stood at INR9.2b. FY25 net profit stood at INR4.85b (vs. a loss of INR16.8b in FY24).

Piramal Enterprises (PIEL) reported 3QFY25 net profit of ~INR386m (PQ: ~INR1.6b). This included exceptional gain of ~INR3.8b (PQ: INR770m) from recoveries in AIF portfolio.

Piramal Enterprises (PIEL) reported a 2QFY25 net profit of ~INR1.6b (PQ: ~INR1.8b). This included an exceptional gain of ~INR770m from recoveries in the AIF portfolio.

PIEL is committed to reducing its legacy AUM from ~INR130b as of Jun’24 to ~INR60-70b by Mar’25 and expects (not guidance) that a ~25% haircut.

PIEL reported 1QFY25 net profit of ~INR1.8b (PQ: ~INR1.4b). This included an exceptional gain of ~INR1b from recoveries in AIF portfolio.

Piramal Enterprises (PEL) reported its first-ever positive quarterly PAT as an NBFC – at Rs35.5bn, well above our estimates. This was its second quarterly result as an NBFC post the demerger of Piramal Pharma. PAT was led by one-offs in terms of: i) income tax provision reversal of Rs33.3bn.

Piramal Enterprises (PEL) once again disappointed, reporting a loss of Rs15bn in Q2FY23, as it provided Rs33bn (>5% of AUM) primarily towards wholesale portfolio.

Piramal Enterprises (PEL) has fixed September 1, ‘22 as demerger of Piramal Pharma record date.